Bromday

Bromday is a brand name of bromfenac ophthalmic, approved by the FDA in the following formulation(s):

BROMDAY (bromfenac sodium - solution/drops; ophthalmic)

• 
  Manufacturer: ISTA PHARMS INC
  
  Approval date: October 16, 2010
  
  Strength(s): 0.09% ^[RLD]

Has a generic version of Bromday been approved?

No. There is currently no therapeutically equivalent version of Bromday available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Bromday. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Bromday.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • October 16, 2013 - NEW PRODUCT
  
  

See also...

• Bromday Consumer Information (Drugs.com)
• Bromday Consumer Information (Wolters Kluwer)
• Bromday Advanced Consumer Information (Micromedex)
• Bromfenac Consumer Information (Wolters Kluwer)
• Bromfenac ophthalmic Consumer Information (Cerner Multum)
• Bromfenac Ophthalmic Advanced Consumer Information (Micromedex)
• Bromfenac Sodium AHFS DI Monographs (ASHP)